By switaschek, 16 October, 2020 Screening generally not recommended1 4 for asymptomatic pts though various groups suggest considering factors for screening in select pts Consider insurance benefits Medicare coverage doesn t extend past 77 yo 3 Encourage tobacco cessation if relevant 1 3
By switaschek, 16 October, 2020 D C screening if darr life expectancy due to health condition1 3 5 or pt unable unwilling to undergo curative tx 2 3 5
By switaschek, 16 October, 2020 Discuss risks benefits including consequences of false continued annual screening employ shared decision making before ordering screen 2 4 6 Consider insurance benefits Medicare coverage doesn t extend past 77 yo 4
By switaschek, 16 October, 2020 Select pts for annual screen current recent smoker quit w in past 15y1 4 5 w 20 pk yr hx per ACCP 1 ACS 2 NCCN 3 ALA 4 USPSTF5 or 30 pk yr hx per AATS6 nbsp nbsp AATS6 specifies screening in pts w 20 pk yr hx only if such pts have additional risk factors
By vgreene, 16 October, 2020 Paroxetine not recommended as 1st line assoc w increased risk of major cardiac malformations unless pt already on paroxetine has planned pregnancy Weigh maternal fetal risks benefits of continuing paroxetine2
By vgreene, 16 October, 2020 2nd gen antidepressant use during pregnancy may be assoc w small increase in risk of preeclampsia postpartum hemorrhage miscarriage perinatal death preterm birth serotonin withdrawal syndrome resp distress pulm hypertension major cardiac malformations new
By switaschek, 16 October, 2020 Use annual low dose CT to screen certain current former smokers Encourage tobacco cessation if relevant 1 4
